Raymond James Trust N.A. Lowers Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Raymond James Trust N.A. reduced its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 50,818 shares of the pharmacy operator’s stock after selling 2,020 shares during the quarter. Raymond James Trust N.A.’s holdings in Walgreens Boots Alliance were worth $455,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of WBA. Charles Schwab Investment Management Inc. boosted its position in Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after purchasing an additional 3,329,857 shares in the last quarter. Thompson Siegel & Walmsley LLC raised its stake in shares of Walgreens Boots Alliance by 98.8% during the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock worth $72,826,000 after buying an additional 2,992,648 shares during the period. Newport Trust Company LLC purchased a new position in shares of Walgreens Boots Alliance during the 2nd quarter valued at approximately $31,028,000. Swedbank AB acquired a new stake in Walgreens Boots Alliance in the 1st quarter valued at $16,365,000. Finally, Philip James Wealth Mangement LLC purchased a new stake in Walgreens Boots Alliance in the 3rd quarter worth $5,252,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 3.6 %

Shares of NASDAQ WBA opened at $8.73 on Wednesday. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $27.05. The company has a market capitalization of $7.55 billion, a P/E ratio of -0.87, a P/E/G ratio of 1.14 and a beta of 0.69. The company has a 50 day simple moving average of $9.13 and a 200-day simple moving average of $11.39. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. The company had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.67 earnings per share. On average, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.45%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio is presently -9.99%.

Analyst Ratings Changes

Several brokerages have recently issued reports on WBA. Jefferies Financial Group dropped their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research report on Wednesday, October 23rd. Truist Financial decreased their target price on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. Morgan Stanley dropped their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research report on Friday, October 11th. Evercore ISI raised their price objective on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a report on Wednesday, October 16th. Finally, UBS Group upped their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $12.88.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.